The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.70
Bid: 50.30
Ask: 50.50
Change: 1.00 (2.01%)
Spread: 0.20 (0.398%)
Open: 49.50
High: 51.00
Low: 49.50
Prev. Close: 49.70
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

15 Jun 2023 13:19

RNS Number : 8821C
IP Group PLC
15 June 2023
 

FOR RELEASE ON

15 June 2023

 

IP Group plc - Results of Annual General Meeting

 

The Annual General Meeting ("AGM") of IP Group plc was held earlier today. All of the Resolutions proposed at the AGM were passed by the appropriate majority on a poll.

 

IP Group plc Annual General Meeting Poll Results

 

 

RESOLUTION

VOTESFOR

%

VOTESAGAINST

%

VOTESTOTAL

% of ISC VOTED

VOTESWITHHELD

1

To receive the Directors' Report, the Audited Statement of Accounts and Auditor's Report of the Company for the financial year ended 31 December 2022.

751,809,999

99.99

23,443

0.01

751,833,442

72.51

5,668,073

2

To approve the Directors' Remuneration Report for the year ended 31 December 2022.

643,188,184

85.99

104,756,327

14.01

747,944,511

72.13

9,557,004

3

To declare the final dividend for the year ended 31 December 2022.

757,477,036

99.99

14,488

0.01

757,491,524

73.05

9,991

4

To re-appoint KPMG LLP as auditor of the Company.

752,189,362

99.30

5,269,236

0.70

757,458,598

73.05

42,917

5

To authorise the Directors to fix the remuneration of KPMG LLP as auditor of the Company.

757,426,619

99.99

32,885

0.01

757,459,504

73.05

42,011

6

To elect Ms Anita Kidgell as Director of the Company.

731,948,592

96.65

25,401,836

3.35

757,350,428

73.04

151,087

7

To re-elect Mr David Baynes as a Director of the Company.

756,498,620

99.88

889,906

0.12

757,388,526

73.04

112,989

8

To re-elect Dr Caroline Brown as a Director of the Company.

749,339,961

98.94

8,049,464

1.06

757,389,425

73.04

112,090

9

To re-elect Mr Heejae Chae as Director of the Company.

719,168,838

94.95

38,217,371

5.05

757,386,209

73.04

115,306

10

To re-elect Sir Douglas Flint as a Director of the Company.

741,859,090

97.95

15,525,370

2.05

757,384,460

73.04

117,055

11

To re-elect Ms Aedhmar Hynes as a Director of the Company.

748,385,828

98.81

9,004,528

1.19

757,390,356

73.04

111,159

12

To re-elect Mr Greg Smith as a Director of the Company.

756,781,301

99.92

610,176

0.08

757,391,477

73.04

110,038

13

To re-elect Dr Elaine Sullivan as a Director of the Company.

736,275,915

97.88

15,952,050

2.12

752,227,965

72.54

5,273,550

14

To authorise the Directors to

exercise all the powers of the Company to allot shares and grant rights to subscribe for or to convert any security into shares in the Company subject to the limits set out in the AGM notice.

750,480,664

99.08

6,960,298

0.92

757,440,962

73.05

60,553

15

To empower the Directors to allot equity securities for cash, or sell treasury shares, dis-applying statutory pre-emption rights subject to the limits set out in the AGM notice.

717,892,773

94.78

39,545,240

5.22

757,438,013

73.05

63,502

16

In addition to the authority granted under Resolution 15, to empower the Directors to allot equity securities in connection with an acquisition or other capital investment as if section 561(1) of the Companies Act 2006 ("Act") did not apply to any such allotment, subject to the limits set out in the AGM notice.

697,425,557

92.08

60,011,259

7.92

757,436,816

73.05

64,699

17

To authorise the Company and its subsidiaries to incur political expenditure (as defined in section 365 of the Act) not exceeding £50,000 in total.

721,657,544

95.27

35,833,896

4.73

757,491,440

73.05

10,075

18

To authorise the Company to make market purchases (as defined in section 693(4) of the Act) of the Company's ordinary shares, subject to the limits set out in the AGM notice.

750,533,731

99.11

6,776,371

0.89

757,310,102

73.03

191,413

19

To enable a general meeting other than an Annual General Meeting to be called on not less than 14 clear days' notice.

746,610,050

98.57

10,861,966

1.43

757,472,016

73.05

29,499

 

 

 

In accordance with Listing Rule 9.6.1, a copy of the Resolutions has been submitted to the National Storage Mechanism and will shortly be available for inspection at:www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.  

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

 

Portland

Vic Wallin

Alex Donaldson

+44 (0) 7973 823119

+44 (0) 7516 729702

 

Notes for editors

 

About IP Group

 

IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxbotica. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGLELFFXQLFBBQ
Date   Source Headline
11th Nov 20216:11 pmRNSTransaction in Own Shares
11th Nov 20217:09 amRNSPortfolio company RFC Power signs JDA with Ceres
10th Nov 20216:22 pmRNSTransaction in Own Shares
9th Nov 20216:12 pmRNSTransaction in Own Shares
8th Nov 20216:11 pmRNSTransaction in Own Shares
5th Nov 20215:24 pmRNSTransaction in Own Shares
4th Nov 20216:08 pmRNSTransaction in Own Shares
3rd Nov 20216:27 pmRNSTransaction in Own Shares
2nd Nov 20216:15 pmRNSTransaction in Own Shares
1st Nov 20216:12 pmRNSTransaction in Own Shares
29th Oct 20215:35 pmRNSTransaction in Own Shares
29th Oct 20212:02 pmRNSPortfolio co Hinge Health completes $400m round
28th Oct 20216:21 pmRNSTransaction in Own Shares
27th Oct 20215:43 pmRNSDirector/PDMR Shareholding
27th Oct 20215:25 pmRNSTransaction in Own Shares
26th Oct 20215:56 pmRNSTransaction in Own Shares
25th Oct 20216:28 pmRNSTransaction in Own Shares
25th Oct 20217:00 amRNSAdditional fair value gain of £27.5m
22nd Oct 20216:29 pmRNSTransaction in Own Shares
21st Oct 20216:00 pmRNSTransaction in Own Shares
20th Oct 20215:56 pmRNSTransaction in Own Shares
19th Oct 20216:31 pmRNSTransaction in Own Shares
19th Oct 20217:00 amRNSTransaction in Own Shares
18th Oct 20217:00 amRNSTransaction in Own Shares
14th Oct 20216:27 pmRNSTransaction in Own Shares
13th Oct 20216:22 pmRNSTransaction in Own Shares
13th Oct 202111:36 amRNSDirector Declaration
13th Oct 20219:03 amRNSHolding(s) in Company
12th Oct 20216:20 pmRNSTransaction in Own Shares
12th Oct 20212:09 pmRNSDirector/PDMR Shareholding
12th Oct 20217:00 amRNSTransaction in Own Shares
11th Oct 20217:41 amRNSTransaction in Own Shares
8th Oct 20217:00 amRNSShare buyback programme
6th Oct 20217:00 amRNSBoard changes
5th Oct 20214:44 pmRNSHolding(s) in Company
30th Sep 20214:11 pmRNSTotal Voting Rights
30th Sep 20217:45 amRNSIP Group generates £84m from Oxford Nanopore IPO
27th Sep 202112:40 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:57 pmRNSFurther re Scrip Dividend
16th Sep 20217:08 amRNSOxford Nanopore confirms ITF; MoU with Oracle
10th Sep 20215:21 pmRNSHolding(s) in Company
8th Sep 202110:53 amRNSDirector/PDMR Shareholding, SAYE scheme
19th Aug 202110:41 amRNSScrip Dividend Reference Price
12th Aug 20215:05 pmRNSDirector Declaration
5th Aug 20217:00 amRNSHalf-yearly results
27th Jul 20217:03 amRNSPortfolio company Artios Pharma raises $153m
22nd Jul 202111:30 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights
28th Jun 20217:30 amRNSDirector/PDMR Shareholding
18th Jun 20219:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.